Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (DFPH) Return on Assets (2020 - 2025)

Historic Return on Assets for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to 0.41%.

  • Oncology Institute's Return on Assets fell 200.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.34% for FY2024, which is 100.0% up from last year.
  • Latest data reveals that Oncology Institute reported Return on Assets of 0.41% as of Q3 2025, which was down 200.0% from 0.41% recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Return on Assets peaked at 0.05% during Q1 2022, and registered a low of 0.41% during Q3 2025.
  • Its 5-year average for Return on Assets is 0.21%, with a median of 0.26% in 2023.
  • As far as peak fluctuations go, Oncology Institute's Return on Assets surged by 1400bps in 2022, and later tumbled by -3900bps in 2023.
  • Quarter analysis of 5 years shows Oncology Institute's Return on Assets stood at 0.05% in 2021, then surged by 101bps to 0.0% in 2022, then tumbled by -69815bps to 0.39% in 2023, then grew by 5bps to 0.37% in 2024, then dropped by -12bps to 0.41% in 2025.
  • Its last three reported values are 0.41% in Q3 2025, 0.41% for Q2 2025, and 0.38% during Q1 2025.